MN-166 (ibudilast) in amyotrophic lateral sclerosis in a Phase IIb/III study: COMBAT-ALS study design

B Oskarsson, N Maragakis, RS Bedlack… - Neurodegenerative …, 2021 - Taylor & Francis
Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease with motor neuron loss
as a defining feature. Despite significant effort, therapeutic breakthroughs have been …

Neuroinflammatory contributions to pain after SCI: roles for central glial mechanisms and nociceptor-mediated host defense

ET Walters - Experimental neurology, 2014 - Elsevier
Neuropathic pain after spinal cord injury (SCI) is common, often intractable, and can be
severely debilitating. A number of mechanisms have been proposed for this pain, which are …

Macrophage migration inhibitory factor (MIF) makes complex contributions to pain-related hyperactivity of nociceptors after spinal cord injury

A Bavencoffe, EA Spence, MY Zhu… - Journal of …, 2022 - Soc Neuroscience
Neuropathic pain is a major, inadequately treated challenge for people with spinal cord
injury (SCI). While SCI pain mechanisms are often assumed to be in the CNS, rodent studies …

A transcriptomic analysis of neuropathic pain in rat dorsal root ganglia following peripheral nerve injury

W Sun, D Kou, Z Yu, S Yang, C Jiang, D Xiong… - Neuromolecular …, 2020 - Springer
The aim of this work is to provide a comprehensive and unbiased understanding at the
molecular correlates of peripheral nerve injury. In this study, we screened the differentially …

Effects of alpha 7 positive allosteric modulators in murine inflammatory and chronic neuropathic pain models

K Freitas, S Ghosh, FI Carroll, AH Lichtman… - Neuropharmacology, 2013 - Elsevier
Agonists and positive allosteric modulators (PAMs) of α7 nicotinic acetylcholine receptors
(nAChRs) are currently being considered as novel therapeutic approaches for managing …

[HTML][HTML] On the therapeutic targets and pharmacological treatments for pain relief following spinal cord injury: A mechanistic review

S Fakhri, F Abbaszadeh, M Jorjani - Biomedicine & Pharmacotherapy, 2021 - Elsevier
Spinal cord injury (SCI) is globally considered as one of the most debilitating disorders,
which interferes with daily activities and life of the affected patients. Despite many …

Pilot study: elevated circulating levels of the proinflammatory cytokine macrophage migration inhibitory factor in patients with chronic spinal cord injury

A Stein, A Panjwani, C Sison, L Rosen, R Chugh… - Archives of physical …, 2013 - Elsevier
Objective To test the hypothesis that the proinflammatory cytokine macrophage migration
inhibitory factor (MIF) is elevated in the circulation of patients with chronic spinal cord injury …

[HTML][HTML] Taselisib moderates neuropathic pain through PI3K/AKT signaling pathway in a rat model of chronic constriction injury

HP You, CJ Xu, LH Zhang, ZY Chen, WF Liu… - Brain Research …, 2023 - Elsevier
Background Neuropathic pain is a chronic condition commonly caused by inflammation-
induced disturbances or lesions of somatosensory functions in the nervous system. The aim …

Macrophage migration inhibitory factor (MIF) is essential for inflammatory and neuropathic pain and enhances pain in response to stress

JK Alexander, GM Cox, JB Tian, AM Zha, P Wei… - Experimental …, 2012 - Elsevier
Stress and glucocorticoids exacerbate pain via undefined mechanisms. Macrophage
migration inhibitory factor (MIF) is a constitutively expressed protein that is secreted to …

How is chronic pain related to sympathetic dysfunction and autonomic dysreflexia following spinal cord injury?

ET Walters - Autonomic Neuroscience, 2018 - Elsevier
Autonomic dysreflexia (AD) and neuropathic pain occur after severe injury to higher levels of
the spinal cord. Mechanisms underlying these problems have rarely been integrated in …